Data Bytes: Roche tops list of pharmas running COVID-19 trials

BioCentury is providing this content for free given the urgent need for information about the coronavirus crisis. Further analysis can be found in our COVID-19 Resource Center. For more, sign up for our daily email.

Pharmas and big biotechs are collectively conducting at least 35 clinical trials for COVID-19, with a further 16 starting soon, according to and

Roche is evaluating Actemra tocilizumab in six of its nine ongoing trials, and one of its upcoming trials. The IL-6 mAb has shown a survival benefit in at least two controlled, investigator-led studies (see “Clinical Scorecard for COVID-19”).

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers